Preliminary results from a clinical trial investigating the safety and immunogenicity of a single booster dose of Sanofi and GSK recombinant adjuvanted COVID-19 vaccine candidate showed consistently strong immune responses regardless of the primary vaccine received. Phase 3 trial continues to accrue number...
• Fluzone • Pentacel • ProQuad/M-M-R- II/Varivax. • Infanrix/Pediarix • Zostavax • RotaTeq • GSK hepatitis Vaccines • Menactra. Our study also divides its overall world vaccines forecast into geographical regions.
RELATED:U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival It wouldn’t be unreasonable to assume that Biktarvy’s future competition might come from inside the company. But there are other HIV treatments Gilead needs to be concerned with. ...